Is Sacubitril/Valsartan a Safe and Effective Option in Real World Patients with Mild to Severe Chronic Kidney Disease?

Is Sacubitril/Valsartan a Safe and Effective Option in Real World Patients with Mild to Severe Chronic Kidney Disease?

Aims: Sacubitril/valsartan has shifted the landscape of heart failure (HF) treatment. As renal function (RF) is often compromised in HF patients, this study aimed to assess the evolution of RF in patients with HF with a reduced ejection fraction (HFrEF) and initiating treatment with sacubitril/valsa...

Full description

Bibliographic Details
Main Authors: Marta Afonso Nogueira, Marisa Brochado, Inês Nabais, Sara Eira, Carla Matias, Gonçalo Proença
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Hearts
Subjects:
heart failure
chronic kidney disease
renal failure
sacubitril/valsartan
angiotensin receptor-neprilysin inhibitor
real world evidence
Online Access:https://www.mdpi.com/2673-3846/3/3/11

Internet

https://www.mdpi.com/2673-3846/3/3/11

Similar Items